Name: Park Ha Biological Technology Co., Ltd. (BYAH) Financial Statements
Creator: FinSpry

Park Ha Biological Technology Co. Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Park Ha Biological Technology Co., Ltd. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Oct 2023	Oct 2022	Oct 2021
Revenue & Gross Profit
Revenue	2.38	2.46	1.92	0.93
Cost of Revenue	0.20	0.31	0.51	0.31
Gross Profit	2.19	2.15	1.41	0.62
Operating Expenses
Research & Development	0.04	0.03	0.06	0.00
Selling, General & Administrative	1.18	0.78	1.15	1.12
Operating Expenses	1.39	0.97	1.21	1.12
Operating Income	0.79	1.18	0.20	-0.50
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00
Other Income/Expense	0.00	0.00	-0.01	0.02
Income
Income Before Tax	0.79	1.18	0.19	-0.48
Income Tax Expense	0.31	0.33	0.00	0.00
Net Income	0.48	0.85	0.19	-0.48
Net Income - Continuous Operations	0.48	0.85	0.19	-0.48
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	0.82	1.20	0.22	-0.46
EBIT	0.79	1.18	0.19	-0.50
Depreciation & Amortization	0.02	0.02	0.03	0.04
Earnings Per Share
Basic EPS	-	-	-	-
Diluted EPS	-	-	-	-
Basic Shares Outstanding	26.20	26.20	26.20	25.00
Diluted Shares Outstanding	26.20	26.20	26.20	25.00